Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo-Reference-Cited by-同舟云学术

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo

Published:2018-01-09 Issue: Volume:8 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Shukla Rahul,Rajpoot Ravi K.,Arora Upasana,Poddar Ankur,Swaminathan Sathyamangalam,Khanna Navin

Funder

Department of Biotechnology, Ministry of Science and Technology

International Centre for Genetic Engineering and Biotechnology

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference51 articles.

1. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification.;Balsitis;PLOS Pathog.,2010

2. Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris.;Batra;J. Biosci. Bioengg.,2010

3. The global distribution and burden of dengue.;Bhatt;Nature,2013

4. Genotype-specific neutralization and protection by antibodies against dengue virus type 3.;Brien;J. Virol.,2010

5. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.;Capeding;Lancet,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Envelope domain III E ₃₂₄ , E ₃₅₁ , and E ₃₈₀ mutations lever adaptive evolution of DENV-1 genotype I;Journal of Virology;2024-09-04

2. Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response;Vaccines;2024-06-14

3. A simple and effective method to remove pigments from heterologous secretory proteins expressed in Pichia pastoris;Advanced Biotechnology;2024-02-08

4. A review on Zika vaccine development;Pathogens and Disease;2024

5. Challenges and Opportunities in the Process Development of Chimeric Vaccines;Vaccines;2023-12-08